References
- von Herbay A, Illes A, Waldherr R, Otto HF. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 1990;66:587-592. https://doi.org/10.1002/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J
- Montero A, Vidaller A, Mitjavila F, Chivite D, Pujol R. Microscopic pulmonary tumoral embolism and subacute cor pulmonale as the first clinical signs of cancer. Acta Oncol 1999;38:1116-1118. https://doi.org/10.1080/028418699432464
- Uruga H, Fujii T, Kurosaki A, et al. Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med 2013;52:1317-1323. https://doi.org/10.2169/internalmedicine.52.9472
- Miyano S, Izumi S, Takeda Y, et al. Pulmonary tumor thrombotic microangiopathy. J Clin Oncol 2007;25:597-599. https://doi.org/10.1200/JCO.2006.09.0670
- Schermuly RT, Dony E, Ghofrani HA, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005;115:2811-2821. https://doi.org/10.1172/JCI24838
Cited by
- Pulmonary tumor thrombotic microangiopathy: a systematic review vol.9, pp.2, 2017, https://doi.org/10.1177/2045894019851000
- Pulmonary hypertension in metastatic breast cancer: a case of pulmonary tumour thrombotic microangiopathy vol.12, pp.9, 2017, https://doi.org/10.1136/bcr-2019-229715